Abstract
The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.
| Originalsprog | Dansk |
|---|---|
| IPC | A61K31/352,A61K38/12,A61K45/06,A61L27/54,A61L29/16,A61P31/04 |
| Patentnummer | DK3641753 (T3) |
| Land/Område | Danmark |
| Prioritetsdato | 19/06/2017 |
| Prioritetsnummer | WO2018EP66234 |
| Status | Udgivet - 12. dec. 2022 |
Citationsformater
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver